Skip to content

Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection

Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00859677
Acronym
MRSA-2
Enrollment
52
Registered
2009-03-11
Start date
2009-03-31
Completion date
2016-08-26
Last updated
2023-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Staphylococcal Infections

Keywords

HIV, Methicillin-resistant Staphylococcus aureus (MRSA), HIV and Staphylococcus aureus infection

Brief summary

The purpose of this study is to investigate the role of T helper 17 cells (Th17) in the pathogenesis of MRSA infections.

Interventions

None listed

Sponsors

Infectious Diseases Clinical Research Program
CollaboratorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

All participant inclusion criteria: * Greater or equal to 18 years of age * Willingness to undergo blood draw. Skin biopsy will be requested, but is optional -AND- HIV-positive and MRSA-negative Group: * Documented positive HIV test result * Negative colonization swabs for S. aureus within 14 days of enrollment * No evidence of skin/soft tissue infection HIV-positive and MRSA-Colonization Group: * Documented positive HIV test result * History of of colonization with MRSA w/in 14 days of study enrollment HIV-positive and MRSA Infection Group: * Documented positive HIV test result * Skin/soft tissue infection with a positive wound culture showing MRSA within 7 days of enrollment * MRSA infection is not associated with an intravenous catheter or other nosocomial procedure HIV Negative groups: * Same criteria used for the HIV-negative groups as listed above. * No history of HIV infection. * Willing to undergo an HIV blood test, which must have a negative result.

Exclusion criteria

* Women with positive urine pregnancy test within 7 days of study enrollment * Women who are within 6 months of being postpartum or who are currently breastfeeding * Subjects unable or unwilling to complete questionnaires and blood draw.

Design outcomes

Primary

MeasureTime frame
To compare distribution of Th17 cells and their functionality, in the peripheral blood of HIV-positive patients who are infected with MRSA with that of HIV-positive patients who are not colonized or infected with Staphylococcus aureus.1 year

Secondary

MeasureTime frame
Compare distribution of Th17 cells in the peripheral blood of groups of HIV-positive and HIV-negative participants who are colonized with MRSA as well as those who have a MRSA infection.1 year
Examine distribution of T cells, B cells, macrophages, dendritic cells, neutrophils, defensins, and IL-17 in T cell subsets in the skin1 year
Compare Th17 cells in peripheral blood of HIV-negative participants with MRSA infection with that of HIV-negative subjects not colonized of infected with Staph aureus.1 year
Collect information on factors that may play a role in development of MRSA colonization/infection. Includes demographic, hygienic, exercise-related, and sexual factors which may contribute to MRSA.1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026